Search
Cullinan Therapeutics Inc
CGEMAdd to Watchlist
15.030USD
+0.590+4.09%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
923.61MMarket Cap
LossP/E TTM
Cullinan Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Cullinan Therapeutics Inc is 7.59, ranking 218 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.04, which is -353.38% below the recent high of 10.23 and -132.55% above the recent low of -9.39.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
